168 related articles for article (PubMed ID: 28428205)
21. Repurposing Vandetanib plus Everolimus for the Treatment of
Carvalho DM; Richardson PJ; Olaciregui N; Stankunaite R; Lavarino C; Molinari V; Corley EA; Smith DP; Ruddle R; Donovan A; Pal A; Raynaud FI; Temelso S; Mackay A; Overington JP; Phelan A; Sheppard D; Mackinnon A; Zebian B; Al-Sarraj S; Merve A; Pryce J; Grill J; Hubank M; Cruz O; Morales La Madrid A; Mueller S; Carcaboso AM; Carceller F; Jones C
Cancer Discov; 2022 Feb; 12(2):416-431. PubMed ID: 34551970
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of
Tinkle CL; Duncan EC; Doubrovin M; Han Y; Li Y; Kim H; Broniscer A; Snyder SE; Merchant TE; Shulkin BL
J Nucl Med; 2019 Mar; 60(3):312-319. PubMed ID: 30072503
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging is the preferred method to assess treatment-related skeletal changes in children with brain tumors.
Kaste SC; Kaufman RA; Gajjar A; Broniscer A
Pediatr Blood Cancer; 2013 Sep; 60(9):1552-6. PubMed ID: 23526749
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models.
Jansen MH; Lagerweij T; Sewing AC; Vugts DJ; van Vuurden DG; Molthoff CF; Caretti V; Veringa SJ; Petersen N; Carcaboso AM; Noske DP; Vandertop WP; Wesseling P; van Dongen GA; Kaspers GJ; Hulleman E
Mol Cancer Ther; 2016 Sep; 15(9):2166-74. PubMed ID: 27325687
[TBL] [Abstract][Full Text] [Related]
25. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity.
Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM
Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166
[TBL] [Abstract][Full Text] [Related]
26. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
Poussaint TY; Kocak M; Vajapeyam S; Packer RI; Robertson RL; Geyer R; Haas-Kogan D; Pollack IF; Vezina G; Zimmerman R; Cha S; Patay Z; Boyett JM; Kun LE
Neuro Oncol; 2011 Apr; 13(4):417-27. PubMed ID: 21297126
[TBL] [Abstract][Full Text] [Related]
27. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
[TBL] [Abstract][Full Text] [Related]
28. Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma.
Ceschin R; Kurland BF; Abberbock SR; Ellingson BM; Okada H; Jakacki RI; Pollack IF; Panigrahy A
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2170-6. PubMed ID: 26338910
[TBL] [Abstract][Full Text] [Related]
29. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
30. MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas.
Makepeace L; Scoggins M; Mitrea B; Li Y; Edwards A; Tinkle CL; Hwang S; Gajjar A; Patay Z
AJNR Am J Neuroradiol; 2020 Feb; 41(2):323-330. PubMed ID: 31974084
[TBL] [Abstract][Full Text] [Related]
31. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children.
Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN
J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851
[TBL] [Abstract][Full Text] [Related]
32. Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.
Ceschin R; Kocak M; Vajapeyam S; Pollack IF; Onar-Thomas A; Dunkel IJ; Poussaint TY; Panigrahy A
J Neurooncol; 2019 May; 143(1):79-86. PubMed ID: 30810873
[TBL] [Abstract][Full Text] [Related]
33. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
[TBL] [Abstract][Full Text] [Related]
34. White matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade glioma.
Liu F; Scantlebury N; Tabori U; Bouffet E; Laughlin S; Strother D; McConnell D; Hukin J; Fryer C; Brière ME; Montour-Proulx I; Keene D; Wang F; Mabbott DJ
Neuro Oncol; 2015 Apr; 17(4):604-13. PubMed ID: 25395463
[TBL] [Abstract][Full Text] [Related]
35. Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas.
Wagner MW; Bell WR; Kern J; Bosemani T; Mhlanga J; Carson KA; Cohen KJ; Raabe EH; Rodriguez F; Huisman TA; Poretti A
Eur J Radiol; 2016 Apr; 85(4):700-6. PubMed ID: 26971411
[TBL] [Abstract][Full Text] [Related]
36. Value of diffusion kurtosis imaging in assessing low-grade gliomas.
Goryawala MZ; Heros DO; Komotar RJ; Sheriff S; Saraf-Lavi E; Maudsley AA
J Magn Reson Imaging; 2018 Dec; 48(6):1551-1558. PubMed ID: 29573042
[TBL] [Abstract][Full Text] [Related]
37. MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.
Jaimes C; Vajapeyam S; Brown D; Kao PC; Ma C; Greenspan L; Gupta N; Goumnerova L; Bandopahayay P; Dubois F; Greenwald NF; Zack T; Shapira O; Beroukhim R; Ligon KL; Chi S; Kieran MW; Wright KD; Poussaint TY
AJNR Am J Neuroradiol; 2020 May; 41(5):874-881. PubMed ID: 32381545
[TBL] [Abstract][Full Text] [Related]
38. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry.
Lazow MA; Nievelstein MT; Lane A; Bandopadhayhay P; DeWire-Schottmiller M; Fouladi M; Glod JW; Greiner RJ; Hoffman LM; Hummel TR; Kilburn L; Leary S; Minturn JE; Packer R; Ziegler DS; Chaney B; Black K; de Blank P; Leach JL
Neuro Oncol; 2022 Sep; 24(9):1598-1608. PubMed ID: 35148393
[TBL] [Abstract][Full Text] [Related]
39. Computation of reliable textural indices from multimodal brain MRI: suggestions based on a study of patients with diffuse intrinsic pontine glioma.
Goya-Outi J; Orlhac F; Calmon R; Alentorn A; Nioche C; Philippe C; Puget S; Boddaert N; Buvat I; Grill J; Frouin V; Frouin F
Phys Med Biol; 2018 May; 63(10):105003. PubMed ID: 29633962
[TBL] [Abstract][Full Text] [Related]
40. Early changes in white matter predict intellectual outcome in children treated for posterior fossa tumors.
Partanen M; Bouffet E; Laughlin S; Strother D; Hukin J; Skocic J; Szulc-Lerch K; Mabbott DJ
Neuroimage Clin; 2018; 20():697-704. PubMed ID: 30219617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
